Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01498809
Recruitment Status :
First Posted : December 23, 2011
Last Update Posted : October 1, 2019
University of British Columbia
Information provided by (Responsible Party):
Andrei Krassioukov, University of British Columbia
This project aims to evaluate the physiological effects of Midodrine administration during orthostatic challenge in those with high level spinal cord injury. Midodrine has been shown to improve orthostatic symptoms in those with spinal cord injury but the physiological mechanisms influenced have not been identified. The investigators will examine key physiological components influencing orthostatic tolerance. The investigators will do this, by measuring the baroreflex, and brain blood flow autoregulation (the ability to maintain brain blood flow) before during and after the sit-up test. Two sit-up tests will occur; one before Midodrine administration, and one after administration of a 10mg dose of Midodrine.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 49 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Individuals with spinal cord injury currently in primary care (less than one year post injury)
To be included in the study, participants must have sustained a traumatic spinal cord injury within the ages of 18-49 years.
Also, participants must have an injury level above the 6th thoracic vertebrae and be a non-smoker for a minimum of one year.
Any participants with a history of cardiovascular disease, pulmonary disease or diabetes mellitus will not be eligible.
Also, participants will not be eligible to take part in study if they experiences acute distress, or are taking medications known to influence cardiovascular function.
Patient will be not eligible for the study if he/she has known adverse reaction to Midodrine.
Keywords provided by Andrei Krassioukov, University of British Columbia:
Orthostatic intolerance in people with spinal cord injury
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Cord Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Autonomic Nervous System Diseases
Signs and Symptoms
Peripheral Nervous System Agents
Physiological Effects of Drugs
Adrenergic alpha-1 Receptor Agonists
Molecular Mechanisms of Pharmacological Action